Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1990-5-23
|
pubmed:abstractText |
In this study it is demonstrated that complement-mediated antibody-dependent enhancement (C'-ADE) of HIV-1 infection in vitro is blocked by murine monoclonal antibodies to CD4 and complement receptor type 2 (CR2) while HIV-1 infection in the absence of C'-ADE is blocked by anti-CD4 but not anti-CR2 monoclonal antibodies. The anti-CR2 murine monoclonal antibody, OKB7, blocked C'-ADE of HIV-1 infection at concentrations greater than 1 microgram/ml. The anti-CD4 monoclonal antibody, OKT4a, but not OKT4f blocked C'-ADE at concentrations greater than 0.06 microgram/ml. HIV-1 infections were quantitated by cytopathic effect, indirect immunofluorescence, and reverse transcriptase release. It appears from these in vitro studies that C'-ADE of HIV-1 infection requires both CD4 and complement receptors while HIV-1 infection in the absence of antibody and complement requires only CD4.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/Complement System Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Complement
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0042-6822
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
175
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
600-4
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2327077-Antibodies, Monoclonal,
pubmed-meshheading:2327077-Antigens, CD4,
pubmed-meshheading:2327077-Binding, Competitive,
pubmed-meshheading:2327077-Cell Line,
pubmed-meshheading:2327077-Complement System Proteins,
pubmed-meshheading:2327077-Cytopathogenic Effect, Viral,
pubmed-meshheading:2327077-Flow Cytometry,
pubmed-meshheading:2327077-HIV Antibodies,
pubmed-meshheading:2327077-HIV-1,
pubmed-meshheading:2327077-Humans,
pubmed-meshheading:2327077-Receptors, Complement
|
pubmed:year |
1990
|
pubmed:articleTitle |
Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors.
|
pubmed:affiliation |
Department of Pathology, Vanderbilt University, Nashville, Tennessee 37232.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|